[1]
2024. Efficacy of palmitoylethanolamide, epilobium and calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Archivio Italiano di Urologia e Andrologia. 96, 2 (Jun. 2024). DOI:https://doi.org/10.4081/aiua.2024.12582.